Question:

I am looking for Medicare billing instructions for calcimimetics delivered for AKI in an ESRD facility. Do you know where this information can be found?

Answer:

One place to find this answer is in transmittal 1941 (issued on October 27, 2017). In this one-time notification (OTN), the Centers for Medicare & Medicaid Services (CMS) provide details on its transitional drug add-on payment adjustment (TDAPA) policy for patients with acute kidney injury (AKI) who are treated in a hospital-based and freestanding end-stage renal disease (ESRD) facility. For this transmittal, go to https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2017Downloads/R1941OTN.pdf.

Facebook
Twitter
LinkedIn
Email
Print

CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.